Jazz Pharmaceuticals Plc (JAZZ)

134.01
2.60 1.98
NASDAQ : Health Technology
Prev Close 131.41
Open 131.42
Day Low/High 131.34 / 134.68
52 Wk Low/High 113.52 / 169.82
Volume 277.93K
Avg Volume 463.00K
Exchange NASDAQ
Shares Outstanding 56.62M
Market Cap 7.44B
EPS 7.50
P/E Ratio 11.34
Div & Yield N.A. (N.A)
8 Stocks Rising on Monster Volume

8 Stocks Rising on Monster Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Trading in an Extended Market

I'm flipping into strength and continuing to look for pockets of momentum.

Sticking With Long Plays

I'm not seeing any real weakness yet to justify a short.

Keep Digging for Opportunities

The dip-buying is good but we need to see stronger momentum and better leadership.

A Gap Up and Fade

The action is strong, but the market isn't gaining additional traction.

Trades Can Still Work When Things Stink

There isn't necessarily any correlation between the way stocks trade and the feeling about the economy.

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Pharmaceuticals (Nasdaq:JAZZ) hit a new 52-week high Monday as it is currently trading at $47.98, above its previous 52-week high of $47.88 with 878,073 shares traded as of 1:25 p.m. ET. Average volume has been 716,000 shares over the past 30 days.

Biotech Has Momentum

Takeover news has the sector buzzing this morning.

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

The Day Ahead: Futures Point Higher

Anticipation of a positive jobs report shows Wall Street edging higher in the early going.

8 Health Care Buys Ahead of Earnings

8 Health Care Buys Ahead of Earnings

Analysts think these eight stocks to have a healthy upside, and all are scheduled to release quarterly earnings next week.

Our September Report Card

Our September Report Card

We had great trades on the euro and the SPX, but we had some bad ones in FXF, SI and JAZZ.

Biotech Is Booming

Biotech Is Booming

Despite the solid performance so far this year, there's still time to get on board and ride the profit train.

S&P 500 on the Edge of a Breakout

S&P 500 on the Edge of a Breakout

If the market likes what it hears from the Fed, we could close above the important 1,219 level.

Chasing Big-Caps

Anticipation of the Fed announcement is likely to keep bids in place and keep the selling from gaining momentum.

Jazz Pharmaceuticals Is Swinging

Jazz Pharmaceuticals Is Swinging

Its chart shows that buyers are becoming more aggressive than sellers.

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Pharmaceuticals (Nasdaq:JAZZ) hit a new 52-week high Friday as it is currently trading at $44.70, above its previous 52-week high of $44.53 with 156,094 shares traded as of 9:46 a.m. ET. Average volume has been 842,700 shares over the past 30 days.

Reacting Instead of Acting

Predatory funds attacked the world markets while U.S. liquidity was on the sidelines due to the Labor Day holiday.

5 Break-Out Stocks: The Search for Survivors

5 Break-Out Stocks: The Search for Survivors

If investors aren't willing to sell a stock off on a significant downtrend, those names could have strong bids underneath them.

Shifting to Defense

Although the short side has been challenging, it makes more sense to lean that way.

Two Pharmas Offer High Potential

Two Pharmas Offer High Potential

The sector is seeing strong revenue, and Jazz and Amarin have the charts to match.

A Bounce Opportunity?

With volatility this high, play tight to avoid a whipsaw if a bounce comes.

Look for the Silver Lining

This currently horrible action will eventually lead to some very good opportunities.

EMC, Jazz Pharma: Analysts' New Ratings

EMC, Jazz Pharma: Analysts' New Ratings

EMC upgraded at Oppenheimer from Perform to Outperform. Jazz Pharmaceuticals upgraded at Jefferies to Buy.

The Day Ahead: Debt Deal Finally Reached

Investors cheered the U.S. debt agreement that Congress will vote on today.

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Pharmaceuticals (Nasdaq:JAZZ) hit a new 52-week high Friday as it is currently trading at $40.13, above its previous 52-week high of $39.08 with 561,061 shares traded as of 10:26 a.m. ET. Average volume has been 735,000 shares over the past 30 days.

5 Stocks Setting Up to Break Out

5 Stocks Setting Up to Break Out

These stocks look poised to break out and trade higher from current prices.

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Stock Hits New 52-Week High (JAZZ)

Jazz Pharmaceuticals (Nasdaq:JAZZ) hit a new 52-week high Thursday as it is currently trading at $36.98, above its previous 52-week high of $36.47 with 212,902 shares traded as of 9:47 a.m. ET. Average volume has been 779,900 shares over the past 30 days.

3M, Toll Brothers: Analysts' New Ratings

3M, Toll Brothers: Analysts' New Ratings

3M downgraded at BofA/Merrill from Neutral to Underperform. Toll Brothers upgraded at Goldman from Neutral to Buy.

Jazz Reaches New 52-Week High (JAZZ)

Jazz Reaches New 52-Week High (JAZZ)

Jazz Pharmaceuticals (Nasdaq:JAZZ) hit a new 52-week high Tuesday as it is currently trading at $35.18, above its previous 52-week high of $34.97 with 238,297 shares traded as of 10:16 a.m. ET. Average volume has been 778,200 shares over the past 30 days.

TheStreet Quant Rating: B- (Buy)